An embarrassment of riches: Neoadjuvant therapy of rectal cancer

Journal of Clinical Oncology

Volumn 23, Issue 7, 2005, Pages 1339-1341

  Tepper, Joel E ^a   Goldberg, Richard M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUOROPYRIMIDINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PYRIMIDINE; TEGAFUR; URACIL;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COLON CANCER; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DRUG DOSE ESCALATION; EDITORIAL; GASTROINTESTINAL TOXICITY; HEALTH CARE ORGANIZATION; HUMAN; MAXIMUM TOLERATED DOSE; MEDICAL SOCIETY; METASTASIS; MONOTHERAPY; PRIORITY JOURNAL; RADIOSENSITIZATION; RECTUM CANCER; RECTUM SURGERY; STAPLER; SURGICAL STAPLING; SURGICAL TECHNIQUE; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; NOTE; RECTUM TUMOR;

CHEMOTHERAPY, ADJUVANT; HUMANS; NEOADJUVANT THERAPY; RECTAL NEOPLASMS;

EID: 14944348747     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.926     Document Type: Editorial

References (7)

1. O'Connell MJ, Martenson J, Wieand H, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
2. Smalley S, Benedetti J, Williamson S, et al: Intergroup 0144-phase III trial of 5-FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer: Bolus 5-FU vs prolonged venous infusion (PVI) before and after XRT vs bolus-5-FU + leucovorin (LV) + levamisole (LEV) before and after XRT + bolus 5-FU + LV. Proc Am Soc Clin Oncol 22:251, 2003
3. Stocchi L, Nelson H, Sargent D, et al: Impact of surgical and pathologic variables in rectal cancer: A United States Community and Cooperative Group report. J Clin Oncol 19:3895-3902, 2001
4. Kapiteijn E, Marijne CAM, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
5. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
6. Tepper JE, O'Connell MJ, Niedzwicki D, et al: Adjuvant therapy in rectal cancer: Analysis by treatment, stage and gender-Final report of INT 0114. J Clin Oncol 20:1744-1750, 2002
7. Hofheinz RD, von Gerstenberg-Helldorf B, Wenz F, et al: Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 23:1350-1357, 2005